Metraipolis › archive › dc_8773e46dd6ce
Altering PTPRD via genetics or pharmacology modulates 3xTg-AD mouse neurofibrillary pathology — Europe PMC PMID:41987927
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41987927
- DOI
- 10.3389/fnins.2026.1803332
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T14:30:48.248Z
- SHA-256 of the archived text
f890f20bf1ddb3d1c5e108e12805206baf11bf5469423b002d8cb5203f3b7940- Stable URL of this page
https://metraipolis.com/documento/dc_8773e46dd6ce
How to cite
Altering PTPRD via genetics or pharmacology modulates 3xTg-AD mouse neurofibrillary pathology — Europe PMC PMID:41987927 — Europe PMC (en), https://europepmc.org/article/MED/41987927 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8773e46dd6ce (Metraipolis archive dc_8773e46dd6ce, sha256 f890f20bf1ddb3d1c5e108e12805206baf11bf5469423b002d8cb5203f3b7940)
BibTeX
@misc{dc8773e46dd6ce,
title = {Altering PTPRD via genetics or pharmacology modulates 3xTg-AD mouse neurofibrillary pathology — Europe PMC PMID:41987927},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41987927},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8773e46dd6ce; sha256 f890f20bf1ddb3d1c5e108e12805206baf11bf5469423b002d8cb5203f3b7940},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41987927. Agents can read the archived copy with the MCP tool read_document.